Protocol development in integrative medicine is not typically a simple process. Individuals require individualized care, and what works for one patient may not work for another.
To establish these protocols, we first developed a Rating Scale that could be used to discern the rigor of evidence supporting a specific nutrient’s therapeutic effect.
The following protocols were developed using only A through C-quality evidence.
A
Systematic review or meta-analysis of human trials
B
RDBPC human trials
2+ studies and/or 1 study with 50 + subjects
C
RDBPC human trials
1 study
Neurological Support – Mood Health
St. John’s wort (Hypericum perforatum)
600 mg, total per day of 0.3 % hypericin and 1-4 % hyperforin standardized formula, minimum 6 weeks2,4,5,6,7
- Hypericum perforatum demonstrated similar efficacy to SSRIs including criteria like remission rate, Hamilton-Anxiety Scale and depressive symptoms in patients with mild to moderate depression1,2
- Improvement in relapse rates, Hamilton-Anxiety Scale, Beck Depression Inventory time courses and greater over-all improvement (Clinical Global Impressions (CGI) scale) was observed. In addition, Hypericum perforatum demonstrated a potential for prophylactic effect in patients with chronic depression or depression alone5,6,7
- Link to interaction white paper: Nutrient Interactions
930-1400 mg EPA 200-750 mg DHA, total per day, minimum 12 weeks11,12
- Dietary n-3 polyunsaturated fatty acids (PUFAs) were shown to lower the risk of depression8,9,10
- Increased levels of red blood cell EPA, DHA and ratio were correlated with improved remission rate12
Rhodiola (Rhodiola rosea)
340 mg, total per day, minimum 6 weeks14,15
- Cell response to stress was shown to be regulated by rhodiola, which in return, positively impacted overall mood13
- Overall depression symptoms including insomnia, somatization and emotional instability were improved15
- A decrease in the Hamilton-Anxiety Scale was observed with fewer adverse effects than sertraline14
Disclaimer
The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.
Upload templateReferences
10
Systematic review or meta-analysis of human trials
a
13
Systematic review or meta-analysis of human trials
a
Fullscript content philosophy
At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.
Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:
- In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
- Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
- A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
- Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
- All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
- Potential conflicts of interest are clearly disclosed.